NCT07673289 Comparative Effect of CIMT and PNFTechnique on Hands Dexterity in Cerebral Palsy
| NCT ID | NCT07673289 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Cerebral Palsy |
| Study Type | INTERVENTIONAL |
| Enrollment | 26 participants |
| Start Date | 2026-01-11 |
| Primary Completion | 2026-06-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 26 participants in total. It began in 2026-01-11 with a primary completion date of 2026-06-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Cerebral Palsy (CP) is a group of permanent disorders of the development of movement and posture, causing activity limitations that are attributed to non-progressive disturbances that occurred in the developing fetal or infant brain. The primary motor impairments in CP often include issues with muscle tone, reflexes, and coordination. Among the various motor disorders associated with CP, impairment of the upper extremities is particularly common and functionally debilitating. Specifically, reduced hand dexterity the ability to perform coordinated, fine motor tasks significantly impacts a child's independence in daily activities such as feeding, dressing, and school-related tasks like writing. Therefore, improving hand function is a critical goal in physiotherapy for this population The objective of this study was to compare the effectiveness of a constraint induced movement therapy ( CIMT ) and Proprioceptive neuromuscular facilitation technique on dexterous movement of hands in cerebral palsy .The study design will be Randomized Controlled Trail. The study setting will be Pediatric Rehabilitation Center or Physiotherapy Department. The duration of study will be 10 months after approval of synopsis. The sample size will be 20 which is calculated by epitools. The sampling technique will be Non-probability convenient sampling . Children who are diagnosed with cerebral palsy will be included. Children with other musculoskeletal and neurological issues will be excluded. Data Collection Tools will be Box and Block test and Pediatric Evaluation of Disability Inventory.. The data will be analyzed using SPSS 23. Keyword Cerebral Palsy, Constraint induced movement therapy (CIMT), dexterous movement, Proprioceptive neuromuscular facilitation
Eligibility Criteria
Inclusion Criteria: * 8 to 13 years of age * Both male and female * Children with moderate level of mental retardation who are able to follow commands Exclusion Criteria: * Children with other musculoskeletal and neurological issues. * Children who have complications such as epilepsy, congenital heart condition
Contact & Investigator
Riaz Baloch, MBBS
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT07673289 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, up to 13 Years, studying Cerebral Palsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07673289 currently recruiting?
Yes, NCT07673289 is actively recruiting participants. Contact the research team at danish.hassan@riphah.edu.pk for enrollment information.
Where is the NCT07673289 trial being conducted?
This trial is being conducted at Lalian, Pakistan.
Who is sponsoring the NCT07673289 clinical trial?
NCT07673289 is sponsored by Riphah International University. The principal investigator is Riaz Baloch, MBBS at Riphah International University. The trial plans to enroll 26 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.